Guillaume Raggiri
Papers
1
Total Citations
30
H-Index
1
About
Guillaume Raggiri is a medicinal chemist and radiochemist whose work has significantly advanced molecular imaging with positron emission tomography (PET). His primary research focuses on the design and synthesis of novel radiotracers for neuroinflammation and cancer imaging, with a particular emphasis on targeting the translocator protein (TSPO) 18 kDa. Raggiri’s most notable contribution is the development of 6-[18F]fluoro-PBR28, a groundbreaking radiotracer that enables non-invasive PET imaging of TSPO expression, a key biomarker for activated microglia in neurological disorders such as Alzheimer’s disease, multiple sclerosis, and traumatic brain injury. His seminal 2011 paper on this synthesis has garnered over 30 citations, underscoring its impact on the field. Beyond this, Raggiri has contributed to the optimization of radiochemical methodologies, improving the efficiency and reproducibility of fluorine-18 labeling for clinical applications. His work bridges synthetic chemistry and translational neuroscience, providing researchers with essential tools to study neuroinflammatory processes in vivo. Raggiri’s achievements highlight his role in advancing precision medicine through targeted radiotracer development.
Research Focus
Key Achievements
Top Papers
- 1